DanielDouglasVon HoffMD

Grant Support

• Methods In Clinical Cancer Research WorkshopNational Cancer Institute2009–2011
• Aurora Kinases As Therapeutic Targets In Pancreatic CancerNational Cancer Institute2007–2010
• Targets To Therapeutics In Pancreatic CancerNational Cancer Institute2005–2009
• Pancreas Cancer Biospecimens RepositoryNational Cancer Institute2005–2009
• Method To Eliminate Pancreatic Cells With Specific Patterns Of Mutations/DeletionNational Cancer Institute2005–2009
• Drug Development CoreNational Cancer Institute2005–2009
• Workshop On Methods In Clinical Cancer ResearchNational Cancer Institute2004–2008
• Clinical Trials Methods Workshop - EuropeNational Cancer Institute2004–2008
• Aurora Kinase As A Therapeutic Target In CancerNational Cancer Institute2005–2006
• Evaluation And Administrative CoreNational Cancer Institute2005
• Aurora Kinase As A Therapeutic Target In CancerNational Cancer Institute2002–2004
• Methods In Clinical Cancer ResearchNational Cancer Institute1996–2003
• Molecular Targets In Colorectal And Pancreatic CancersNational Cancer Institute2002
• Cancer Center Support GrantNational Cancer Institute1999–2002
• Methods In Clinical Cancer Research (Europe): A WorkshopNational Cancer Institute2000–2001
• Novel A RING And E RING Modified Camptothecin AnalogsNational Cancer Institute1999–2001
• Phase I Clinical And Pharmacokinetic Evaluation Of Ly295501National Center For Research Resources1998–2000
• Phase I Trial Of Rhizoxin Administered As A 72 HR IV InfusionNational Center For Research Resources1997–2000
• Telomere And Telomerase Interactive AgentsNational Cancer Institute1999
• Methods In Clinical Cancer Research (Europe)--A WorkshopNational Cancer Institute1999
• Cancer Center Control InitiativeNational Cancer Institute1999
• Phase I Trial Of Intratumoral Injection Of ONYX-015 Into Head, Neck TumorsNational Center For Research Resources1998–1999
• Phase I Study Of Oral CPT-11 Given Daily X 5 Every 3 WeeksNational Center For Research Resources1998–1999
• Phase I Of LU103793 As 5 MIN IV In Patients With Solid TumorsNational Center For Research Resources1996–1999
• Telomere And Telomerase Interactive AgentsNational Cancer Institute1995–1999
• Phase I/II Ascending Dose Trial Of SDZ MKT 077 In Single Weekly Doses Given IVNational Center For Research Resources1997
• Phase I Trial Of Intratumoral Injection Of Onyx-05 Into Head, Neck TumorsNational Center For Research Resources1997
• Phase I Of Paclitaxel Administered As A 3 Hour InfusionNational Center For Research Resources1996–1997
• Phase I Clinical Trials Of Anticancer AgentsNational Cancer Institute1995–1997
• Phase I Trial Of LY231514 Administered As A BolusNational Center For Research Resources1996
• Phase I Trial Of Ds-4152 Administered As A 30 Minute InfusionNational Center For Research Resources1994
• Phase I Trial Of Ct-150r In Cancer Patients In Thiotepa TherapyNational Center For Research Resources1994
• Phase I Study Of Rp56976 Administered As A 2-Hour Infusion Every 21 DaysNational Center For Research Resources1994
• Fludarabine Phosphate In Subjects With Advanced CancerNational Center For Research Resources1994
• Assessing The Safety Of Recombinant Human Ciliary Neurotrophic Factor (RHCNTF)National Center For Research Resources1994
• Phase I Trial Of U73975National Center For Research Resources1993–1994
• Phase I Trial Of Topotecan Administered As A Continuous Infusion For 5 DaysNational Center For Research Resources1993–1994
• Phase I Trial Of TetraplatinNational Center For Research Resources1993–1994
• Phase I Trial Of A Weekly Dose Of CPT-11National Center For Research Resources1993–1994
• Gallium In Non-Hodgkin'S Lymphoma In AIDS PatientsNational Cancer Institute1993–1994
• Elimination Of Extrachromosomal DNA From Ovarian CancerNational Cancer Institute1992–1994
• Study Of Intravenous Ilmofosine Administered Once A Day For 5 Days Every 28 DaysNational Center For Research Resources1993
• Phase I Study Of Terephthalamidine On A 5 Day Continuous InfusionNational Center For Research Resources1993
• Phase I Study Of Rp56976 Administered As A 2 HR Infusion Every 21 DaysNational Center For Research Resources1993
• Evaluation Of 7u85 Mesylate Administered Intravenously Daily For 5 DaysNational Center For Research Resources1993
• Phase I Trial Of Hycamptamine (Sk&F 104864)National Center For Research Resources1990
• Phase I Trial Of Hepsulfam Administered As A Single Dose Every 21 DaysNational Center For Research Resources1990
• Phase I Evaluation Of Amap-F On A Single Dose ScheduleNational Center For Research Resources1990
• Randomized Clinical Trial Of A Capillary Cloning SystemNational Cancer Institute1987–1990
• Perfused Capillary System For Cloning Human TumorsNational Cancer Institute1985–1987
• Tiazofurin Therapy EvaluationNational Center For Research Resources1985
• Phase I Trial Of Dideminin BNational Center For Research Resources1985
• Phase I Testing Of RiboxamineNational Center For Research Resources1985
• Combined Chemotherapy Of Head And Neck CancerNational Center For Research Resources1985